Segment, Customer and Geographical Reporting (Details) (USD $)	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2013
Segment Reporting Information [Line Items]
Revenue	$ 10,711,528	$ 10,553,275
Gross Profit	4,450,528	4,626,866
Operating Income (Loss)	1,614,218	(191,287)
Depreciation and Amortization	266,325	426,458
Capital expenditures	130,918	315,568
Intangibles, Net	1,357,492	6,527,608	3,484,583
Goodwill	6,256,323	10,264,499	6,240,983
Total Assets	24,155,303	36,379,675	26,677,226
Contract Research [Member]
Segment Reporting Information [Line Items]
Revenue	5,840,442	4,910,840
Gross Profit	2,529,539	2,214,053
Operating Income (Loss)	348,394	(606)
Depreciation and Amortization	69,547	62,782
Capital expenditures	0	186,330
Intangibles, Net	324,185	339,886
Goodwill	4,938,625	4,938,625
Total Assets	10,359,612	13,290,669
Optics [Member]
Segment Reporting Information [Line Items]
Revenue	4,098,508	4,251,940
Gross Profit	1,597,259	1,700,555
Operating Income (Loss)	398,428	385,676
Depreciation and Amortization	178,108	185,628
Capital expenditures	130,918	122,146
Intangibles, Net	869,974	946,525
Goodwill	1,317,698	1,310,802
Total Assets	12,538,356	10,607,828
Instruments [Member]
Segment Reporting Information [Line Items]
Revenue	772,578	1,284,038
Gross Profit	323,730	605,801
Operating Income (Loss)	1,041,768	(455,694)
Depreciation and Amortization	2,003	163,048
Capital expenditures	0	7,092
Intangibles, Net	0	5,016,201
Goodwill	0	4,015,072
Total Assets	752,431	12,092,507
Biomedical [Member]
Segment Reporting Information [Line Items]
Revenue	0	106,457
Gross Profit	0	106,457
Operating Income (Loss)	(174,372)	(120,663)
Depreciation and Amortization	16,667	15,000
Capital expenditures	0	0
Intangibles, Net	163,333	224,996
Goodwill	0	0
Total Assets	$ 504,904	$ 388,671